Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Lung cancer screening in Lithuania: a cost-effectiveness analysis
Hilde ten Berge
,
Greta Piazza
,
Dianne Ramaker
,
Xuanqi Pan
,
Titas Bukšnys
,
Saulius Cicėnas
,
Skaidrius Miliauskas
,
Giedre Smailyte
,
Rolandas Zablockis
,
Marius Zemaitis
, and
Edvardas Danila
Journal of Comparative Effectiveness Research
16 Jul 2026
Real-world comparative effectiveness of analogue and human insulin on glycemic control in children and adolescents with Type 1 diabetes in Lebanon using continuous glucose monitoring data
Sahar Masri
,
Manuel Albela
,
Iza Ciglenecki
,
Philippa Boulle
,
Tania Hachem
,
Sola Bahous
,
David Prieto-Merino
, and
Pablo Perel
Journal of Comparative Effectiveness Research
16 Jul 2026
Nucs AI and Segmed to advance AI-driven precision oncology with real-world data
The Evidence Base
16 Jul 2026
Market access and HTA developments with Sreeram Ramagopalan: The HEMA benefits debate and delays in health plan coverage updates
The Evidence Base
15 Jul 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
16 Jul 2026
Nucs AI and Segmed to advance AI-driven precision oncology with real-world data
15 Jul 2026
Market access and HTA developments with Sreeram Ramagopalan: The HEMA benefits debate and delays in health plan coverage updates
15 Jul 2026
Following the patient journey: How connected data and evolving methods are reshaping real-world evidence
15 Jul 2026
Market access and HTA developments with Sreeram Ramagopalan: The HEMA benefits debate and delays in health plan coverage updates
14 Jul 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in June 2026
9 Jul 2026
Second and third Joint Clinical Assessments published, addressing all Member State PICOs with comparative evidence
15 Jul 2026
Following the patient journey: How connected data and evolving methods are reshaping real-world evidence
15 Jul 2026
ISPOR Special Task Force introduces IMPACT framework for value-based healthcare implementation
14 Jul 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in June 2026
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
16 Jul 2026
Nucs AI and Segmed to advance AI-driven precision oncology with real-world data
15 Jul 2026
Market access and HTA developments with Sreeram Ramagopalan: The HEMA benefits debate and delays in health plan coverage updates
15 Jul 2026
Following the patient journey: How connected data and evolving methods are reshaping real-world evidence
15 Jul 2026
ISPOR Special Task Force introduces IMPACT framework for value-based healthcare implementation
.png)
.png)
